Cargando…
Shen-Ling-Bai-Zhu-San for ulcerative colitis: Protocol for a systematic review and meta-analysis
BACKGROUND: Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) at the colonic mucosa and submucosa. Shen-Ling-Bai-Zhu-San (SLBZS) is one of the most common formulations of traditional Chinese medicine (TCM) for the treatment of UC. However, its effects and safety remain uncertain....
Autores principales: | Yang, Long, Song, Yuanyuan, Jin, Pei, Liu, Yueyang, Wang, Yue, Qiao, Huixia, Huang, Yahui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160248/ https://www.ncbi.nlm.nih.gov/pubmed/30235688 http://dx.doi.org/10.1097/MD.0000000000012337 |
Ejemplares similares
-
Effects of ShenLing BaiZhu San Supplementation on Gut Microbiota and Oxidative Stress in Rats with Ulcerative Colitis
por: Gu, Daxing, et al.
Publicado: (2021) -
Systems Pharmacology and Microbiome Dissection of Shen Ling Bai Zhu San Reveal Multiscale Treatment Strategy for IBD
por: Lv, Wei-jie, et al.
Publicado: (2019) -
Effects of Chaihu-Shugan-San and Shen-Ling-Bai-Zhu-San on p38 MAPK Pathway in Kupffer Cells of Nonalcoholic Steatohepatitis
por: Yang, Qin-He, et al.
Publicado: (2014) -
Efficacy and safety of Shen-Ling-Bai-Zhu-San combined with chemotherapy for lung cancer: A protocol for systematic review and meta-analysis
por: Jiang, Jiawang, et al.
Publicado: (2021) -
Chinese herbal formula shen-ling-bai-zhu-san to treat chronic gastritis: Clinical evidence and potential mechanisms
por: Jin, Wei, et al.
Publicado: (2022)